Skip to main content
Livermore
Livermore
ZHEN

Cerity Partners LLC

SEC CIK
0001566475
Latest filing
Aug 14, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Cerity Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
160,601
Value
$2.57M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by Cerity Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026160,601$2.57M<0.1%+24,213+17.8%AddedHolders
Q1 2026136,388$2.53M<0.1%+14,728+12.1%AddedHolders
Q4 2025121,660$1.90M<0.1%−33,829−21.8%ReducedHolders
Q3 2025155,489$2.28M<0.1%−4,374−2.7%ReducedHolders
Q2 2025159,863$2.47M<0.1%+578+0.4%AddedHolders
Q1 2025159,285$2.37M<0.1%+71,634+81.7%AddedHolders
Q4 202487,651$1.20M<0.1%−39,420−31.0%ReducedHolders
Q3 2024127,071$1.81M<0.1%+61,271+93.1%AddedHolders
Q2 202465,800$851.5K<0.1%−47,071−41.7%ReducedHolders
Q1 2024112,871$1.57M<0.1%+49,903+79.3%AddedHolders
Q4 202362,968$898.6K<0.1%−4,556−6.7%ReducedHolders
Q3 202367,524$1.04M<0.1%+7,301+12.1%AddedHolders
Q2 202360,223$945.8K<0.1%−2,072−3.3%ReducedHolders
Q1 202362,295––+7,304+13.3%AddedHolders
Q4 202254,991$857.6K<0.1%−22,936−29.4%ReducedHolders
Q3 202277,927$1.01M<0.1%+24,365+45.5%AddedHolders
Q2 202253,562$752.0K<0.1%+21,366+66.4%AddedHolders
Q1 202232,196$459.0K<0.1%+13,507+72.3%AddedHolders
Q4 202118,689$253.0K<0.1%+4,904+35.6%AddedHolders
Q3 202113,785$226.0K<0.1%−34−0.2%ReducedHolders
Q2 202113,819$233.0K<0.1%−882−6.0%ReducedHolders
Q1 202114,701$268.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.